XML 20 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Series B Preferred Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance, preferred stock (in shares) at Jan. 31, 2022       0 0        
Beginning balance, common stock (in shares) at Jan. 31, 2022           35,759,000      
Beginning balance, treasury stock (in shares) at Jan. 31, 2022             (230,000)    
Beginning balance at Jan. 31, 2022 $ 8,109     $ 0 $ 0 $ 0 $ (150) $ 20,588 $ (12,329)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation $ 110             110  
Stock issued for the exercise of options (in shares) 130,000         57,000      
Stock issued for the exercise of options $ 26             26  
Stock issued for the acquisition of equity investment (in shares)           502,000      
Stock issued for the acquisition of equity investment 700             700  
Issuance of Preferred B Shares, net of issuance costs (in shares)     55,000   55,000        
Issuance of Preferred B Shares, net of issuance costs 1,300   $ 1,300         1,300  
Series B Preferred dividend (34)               (34)
Net income $ 2,304               2,304
Ending balance, preferred stock (in shares) at Jan. 31, 2023   0 54,600 0 55,000        
Ending balance, common stock (in shares) at Jan. 31, 2023 36,087,857         36,318,000      
Ending balance, treasury stock (in shares) at Jan. 31, 2023 (230,000)           (230,000)    
Ending balance at Jan. 31, 2023 $ 12,515     $ 0 $ 0 $ 0 $ (150) 22,724 (10,059)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock based compensation (in shares)           138,000      
Stock-based compensation 486             486  
Stock issued for the exercise of options and warrants (in shares)           213,000      
Stock issued for the exercise of options and warrants $ 68             68  
Stock issued for the exercise of options (in shares) 232,500                
Conversion of Series B preferred stock (in shares)         55,000 819,000      
Series B Preferred dividend $ (49)               (49)
Net income $ 6,561               6,561
Ending balance, preferred stock (in shares) at Jan. 31, 2024   0 0 0 0        
Ending balance, common stock (in shares) at Jan. 31, 2024 37,258,239         37,488,000      
Ending balance, treasury stock (in shares) at Jan. 31, 2024 (230,000)           (230,000)    
Ending balance at Jan. 31, 2024 $ 19,581     $ 0 $ 0 $ 0 $ (150) $ 23,278 $ (3,547)